Candel Therapeutics, Inc. (CADL) NASDAQ

5.22

+0.115(+2.25%)

Updated at October 01 10:49AM

Currency In USD

Valuation

Market Cap274.94M
Enterprise Value185.76M
P/E Ratio-12.13
PEG Ratio-0.23
Price/Sales Ratio286.3
Price/Book Ratio2.98
Enterprise/Revenue193.96
Enterprise/EBITDA-5.42

Fiscal Year

Fiscal YearDecember 31, 2024
Most Recent QuarterJune 30, 2025

Profitability

Profit Margin-22.14
Operating Margin-36.21

Management Effectiveness

Return On Assets-0.21
Return On Equity-0.41

Income Statement

Revenue0
Revenue/Share0.02
Gross Profit-990,000
EBITDA-52.1M
Net Income-55.18M
Diluted EPS-1.74

Balance Sheet

Total Cash100.69M
Total Cash/Share1.96
Total Debt8.34M
Total Debt/Equity0.09
Current Ratio7.04
Book Value Per Share1.75

Price History

52-Week Change-25.5
52-Week High14.6
52-Week Low3.79
Moving Average 50 Days5.74
Moving Average 200 Days6.47

Statistics

Average Volume809,939
Shares Outstanding54.9M
% Held by Institutions72.73

Dividend And Splits

Trailing Annual Dividend Rate0
Trailing Annual Dividend Yield0
Payout Ratio0
Last Split FactorN/A
Last Split DateN/A